As of April 2025 Pacific Biosciences has a market cap of NZ$0.65 Billion. This makes Pacific Biosciences the world's 7222th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$0.65 B | -32.09% |
2024 | NZ$0.97 B | -76.6% |
2023 | NZ$4.14 B | 42.41% |
2022 | NZ$2.91 B | -55.91% |
2021 | NZ$6.60 B | -1.83% |
2020 | NZ$6.73 B | 475.97% |
2019 | NZ$1.16 B | -29.5% |
2018 | NZ$1.65 B | 283.57% |
2017 | NZ$0.43 B | -14.98% |
2016 | NZ$0.50 B | -66.88% |
2015 | NZ$1.53 B | 107.43% |
2014 | NZ$0.73 B | 75.37% |
2013 | NZ$0.42 B | 263.38% |
2012 | NZ$0.11 B | -40.97% |
2011 | NZ$0.19 B | -81.96% |
2010 | NZ$1.09 B |
On Apr 1st, 2025 the market cap of Pacific Biosciences was reported to be: